United States · FDA National Drug Code directory
Ciclopirox
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-141_d75239bb-7620-45a8-9c3b-a41e4baa48dc
- Product NDC
- 45802-141
- Form
- SOLUTION
- Composition / generic term
- Ciclopirox
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070919
- Source listing expiry
- 20261231
Source-listed ingredients
- CICLOPIROX — 80 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-141-67) / 6.6 mL in 1 BOTTLE, WITH APPLICATOR · 45802-141-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →